This is a Validated Antibody Database (VAD) review about human TYRP1, based on 11 published articles (read how Labome selects the articles), using TYRP1 antibody in all methods. It is aimed to help Labome visitors find the most suited TYRP1 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
TYRP1 synonym: CAS2; CATB; GP75; OCA3; TRP; TRP1; TYRP; b-PROTEIN; 5,6-dihydroxyindole-2-carboxylic acid oxidase; DHICA oxidase; catalase B; glycoprotein 75; melanoma antigen gp75

Abcam
mouse monoclonal (TA99)
  • immunocytochemistry; human; 1:40; loading ...; fig 4g
  • immunocytochemistry; mouse; 1:200; fig 1b
In order to study the function of the RAB6 secretory pathway melanosome formation and maturation, Abcam TYRP1 antibody (Abcam, TA99) was used in immunocytochemistry on human samples at 1:40 (fig 4g) and in immunocytochemistry on mouse samples at 1:200 (fig 1b). Nat Commun (2017) ncbi
rabbit monoclonal (EPR13063)
  • western blot; mouse; 1:10,000; loading ...; fig 2e
Abcam TYRP1 antibody (Abcam, ab178676) was used in western blot on mouse samples at 1:10,000 (fig 2e). Redox Biol (2016) ncbi
mouse monoclonal (TA99)
  • immunohistochemistry - frozen section; mouse; fig 4
In order to study how focused, low-intensity ultrasound can reverse tumor-induced T cell tolerance and prevent immune escape, Abcam TYRP1 antibody (Abcam, ab3312) was used in immunohistochemistry - frozen section on mouse samples (fig 4). J Immunol (2016) ncbi
mouse monoclonal (TA99)
  • western blot; mouse; fig 4
In order to study engineered anti-melanoma vaccines that modulate cytokine priming and silence PD-L1 simultaneously by use of ex vivo myeloid-derived suppressor cells as a readout of therapeutic efficacy, Abcam TYRP1 antibody (Abcam, ab3312) was used in western blot on mouse samples (fig 4). Oncoimmunology (2014) ncbi
Santa Cruz Biotechnology
mouse monoclonal (23)
  • western blot; mouse; 1:200; loading ...; fig 1b
Santa Cruz Biotechnology TYRP1 antibody (Santa Cruz Biotechnology, Sc-136388) was used in western blot on mouse samples at 1:200 (fig 1b). Invest Ophthalmol Vis Sci (2018) ncbi
mouse monoclonal (TA99)
  • western blot; rat; fig s1
Santa Cruz Biotechnology TYRP1 antibody (Santa Cruz, sc58438) was used in western blot on rat samples (fig s1). Sci Rep (2016) ncbi
mouse monoclonal (G-9)
  • western blot; human
Santa Cruz Biotechnology TYRP1 antibody (Santa Cruz, SC-166857) was used in western blot on human samples . Mol Vis (2014) ncbi
BioLegend
mouse monoclonal (TA99)
  • immunohistochemistry - frozen section; human; fig 2b
In order to investigate the basis for T regulatory cell accumulation in melanoma, BioLegend TYRP1 antibody (Covance, Ta99) was used in immunohistochemistry - frozen section on human samples (fig 2b). Cancer Res (2016) ncbi
mouse monoclonal (TA99)
  • immunohistochemistry; human; 1:100; loading ...; fig 6j
In order to examine the role of epithelial-mesenchymal transition in keloid pathology, BioLegend TYRP1 antibody (BioLegend, 917801) was used in immunohistochemistry on human samples at 1:100 (fig 6j). Burns Trauma (2016) ncbi
mouse monoclonal (TA99)
  • immunocytochemistry; human
In order to discover regulatory networks from epigenomes of surface ectoderm-derived cell types, BioLegend TYRP1 antibody (Covance, Sig-38150) was used in immunocytochemistry on human samples . Nat Commun (2014) ncbi
Sigma-Aldrich
rabbit polyclonal
  • immunocytochemistry; human; fig 2
Sigma-Aldrich TYRP1 antibody (Sigma-Aldrich, SAB2102617) was used in immunocytochemistry on human samples (fig 2). Exp Ther Med (2017) ncbi
Articles Reviewed
  1. Onojafe I, Megan L, Melch M, Aderemi J, Alur R, Abu Asab M, et al. Minimal Efficacy of Nitisinone Treatment in a Novel Mouse Model of Oculocutaneous Albinism, Type 3. Invest Ophthalmol Vis Sci. 2018;59:4945-4952 pubmed publisher
  2. Patwardhan A, Bardin S, Miserey Lenkei S, Larue L, Goud B, Raposo G, et al. Routing of the RAB6 secretory pathway towards the lysosome related organelle of melanocytes. Nat Commun. 2017;8:15835 pubmed publisher
  3. Zhu M, Ma H, Zhan Z, Liu C, Luo W, Zhao G. Detection of auto antibodies and transplantation of cultured autologous melanocytes for the treatment of vitiligo. Exp Ther Med. 2017;13:23-28 pubmed publisher
  4. Klarquist J, Tobin K, Farhangi Oskuei P, Henning S, Fernandez M, Dellacecca E, et al. Ccl22 Diverts T Regulatory Cells and Controls the Growth of Melanoma. Cancer Res. 2016;76:6230-6240 pubmed
  5. Hahn J, McFarland K, Combs K, Supp D. Partial epithelial-mesenchymal transition in keloid scars: regulation of keloid keratinocyte gene expression by transforming growth factor-?1. Burns Trauma. 2016;4:30 pubmed publisher
  6. Asalla S, Girada S, Kuna R, Chowdhury D, Kandagatla B, Oruganti S, et al. Restoring Mitochondrial Function: A Small Molecule-mediated Approach to Enhance Glucose Stimulated Insulin Secretion in Cholesterol Accumulated Pancreatic beta cells. Sci Rep. 2016;6:27513 pubmed publisher
  7. Chaiprasongsuk A, Onkoksoong T, Pluemsamran T, Limsaengurai S, Panich U. Photoprotection by dietary phenolics against melanogenesis induced by UVA through Nrf2-dependent antioxidant responses. Redox Biol. 2016;8:79-90 pubmed publisher
  8. Bandyopadhyay S, Quinn T, Scandiuzzi L, Basu I, Partanen A, Tomé W, et al. Low-Intensity Focused Ultrasound Induces Reversal of Tumor-Induced T Cell Tolerance and Prevents Immune Escape. J Immunol. 2016;196:1964-76 pubmed publisher
  9. Liechtenstein T, Perez Janices N, Blanco Luquin I, Goyvaerts C, Schwarze J, Dufait I, et al. Anti-melanoma vaccines engineered to simultaneously modulate cytokine priming and silence PD-L1 characterized using ex vivo myeloid-derived suppressor cells as a readout of therapeutic efficacy. Oncoimmunology. 2014;3:e945378 pubmed
  10. Lowdon R, Zhang B, Bilenky M, Mauro T, Li D, Gascard P, et al. Regulatory network decoded from epigenomes of surface ectoderm-derived cell types. Nat Commun. 2014;5:5442 pubmed publisher
  11. Poliakov E, Strunnikova N, Jiang J, Martinez B, Parikh T, Lakkaraju A, et al. Multiple A2E treatments lead to melanization of rod outer segment-challenged ARPE-19 cells. Mol Vis. 2014;20:285-300 pubmed